Dr. Staddon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
230 W Washington Sq
2nd Floor
Philadelphia, PA 19106Phone+1 215-829-6088Fax+1 215-829-6104
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1977 - 1980
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1972 - 1975
- Perelman School of Medicine at the University of PennsylvaniaClass of 1972
Certifications & Licensure
- PA State Medical License 1973 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2013-2014
- Philadelphia Magazine Castle Connolly, 2008, 2011-2014
- America's Top Doctors for Cancer Castle Connolly, 2012-2013
- Join now to see all
Clinical Trials
- Safety Study of PLX108-01 in Patients With Solid Tumors Start of enrollment: 2009 Oct 01
- Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2011 May 01
- Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 377 citationsSafety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase ...Sant P. Chawla, Robert M. Henshaw, Leanne L. Seeger, Edwin Choy, Jean-Yves Blay
The Lancet. Oncology. 2013-08-01 - 535 citationsEfficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Rando...George D. Demetri, Margaret von Mehren, Robin L. Jones, Martee L. Hensley, Scott M. Schuetze
Journal of Clinical Oncology. 2016-09-19 - 366 citationsStructure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.William D. Tap, Zev A. Wainberg, Stephen P. Anthony, Prabha N. Ibrahim, Chao Zhang
The New England Journal of Medicine. 2015-07-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: